What is HC Wainwright’s Forecast for Genmab A/S Q2 Earnings?
Genmab A/S (NASDAQ:GMAB – Free Report) – Research analysts at HC Wainwright lifted their Q2 2025 earnings per share estimates for Genmab A/S in a research note issued on Wednesday, April 9th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings per share of $0.41 for the quarter, up from their […]
